CAMBRIDGE, Mass., April 19, 2017 /PRNewswire/ -- Leading renal researchers, Professor Vlado Perkovicand Dr. David Charytan will give a joint talk entitled Ambitious Protocols, Complex Trials and Scientific Leadership in Cambridge at 6 p.m. on the 26th
Professor Vlado Perkovic, widely considered a world authority in the fields of hypertension, cardiovascular disease, and nephrology, is the Executive Director of The George Institute for Global Health Australia, and Professor of Medicine at University of Sydney. His research focus is in clinical trials and epidemiology, in particular in understanding both the cardiovascular risk associated with kidney disease and the impact of interventions that might mitigate this risk. He has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management.
Dr. David Charytan, a scientific and academic leader in renal clinical research, serves as Director of ICU Nephrology at Brigham and Women's Hospital, Assistant Professor of Medicine at Harvard Medical School, and Director of Renal Research at Balm Institute. Dr. Charytan's major focus concerns utilization rates and outcomes of interventional and medical therapies for cardiovascular disease in the setting of chronic kidney disease as well as the contribution of microvascular disease to cardiovascular death in the setting of impaired kidney function. His studies have highlighted concerns related to the use of standard therapy for coronary disease in the setting of chronic kidney disease. Dr. Charytan also has extensive experience using various techniques to analyze administrative data sources related to cardiovascular therapeutics.
The event is the first in a series of talks sponsored by George Clinical, an Asia focused CRO with global capabilities. This talk aims to provide a number of practical examples of how scientific/academic leadership can have a positive, cost-effective impact on complex trial delivery.
The talk, accompanied by drinks and hors d'oeuvres will be held at:
350 Third Street, CAMBRIDGE, MA 02142
Seats are limited so please contact Kristina Figueroa at:
[email protected] or +1 919 339 8997
About George Clinical
George Clinical is a leading independent clinical research organisation (CRO) in Asia with over 200 staff operating in 11 countries. George Clinical provides the full range of clinical trial services to pharmaceutical, medical device and biotech customers, for all trial phases, registration and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery capability to create a distinctive world-class service. George Clinical's parent organization, The George Institute for Global Health, is a leader in chronic disease research, with a global network of experts with whom George Clinical engages. George Clinical delivers an operationally supported, internationally recognized scientific leadership service, providing motivation and engagement to trial investigators at a peer to peer level. George Clinical provides customizable clinical trial excellence from trial design through all aspects of delivery. Their website is www.georgeclinical.com or follow us on LinkedIn, Facebook and Twitter @george_clinical
About The George Institute
The George Institute for Global Health
The George Institute for Global Health is improving the lives of millions of people worldwide through innovative health research. Working across a broad health landscape, the Institute conducts clinical, population and health system research aimed at changing health practice and policy worldwide. The Institute has a global network of medical and health experts working together to address the leading causes of death and disability worldwide. Established in Australia and affiliated with The University of Sydney, the Institute today also has offices in China, India and the United Kingdom, and is also affiliated with Peking University Health Science Centre, the University of Hyderabad and the University of Oxford. Follow them on Twitter @georgeinstitute
About Baim Institute
The Baim Institute for Clinical Research (Baim Institute) is a not-for-profit corporation created by the Harvard Medical School, Partners Healthcare and the Beth Israel Deaconess Medical Center. Baim Institute's governance consists of a Board of Trustees comprised of leading representatives from these institutions.
Baim Institute's mission is to facilitate greater academic involvement in clinical research by serving as a leading center of clinical data management and analysis. Baim Institute employs approximately 150 research professionals in areas such as biostatistics, site management and monitoring, project management, database programming and management, medical management, information technology, and quality assurance.
Since inception, Baim Institute has conducted over 300 trials, and assisted in the submission of more than 50 applications to the FDA. As a result, Baim Institute has developed extensive experience in managing and analyzing clinical trial data for commercial, academic, and scientific purposes.
Please visit their website at https://www.baiminstitute.org/ and follow us on Twitter @BaimInstitute.
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/scientific-leaders-in-renal-research-to-give-keynote-talk-in-cambridge-300441831.html
SOURCE George Clinical
Subscribe to our Free Newsletters!
Adult immunization is needed for adults whose mandatory childhood vaccines were either missed out ...
Snake antivenom is a medicine used for the treatment of patients suffering from snake envenomation.
Breast Cancer Risk Assessment Calculator predicts the risk for breast cancer. Find list of breast ...View All